University of Pennsylvania

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1740-11-14

Employees: 5K

Market Cap: -

Website: http://www.upenn.edu

Clinical Trials

Pharmacokinetic Characteristics and Anti-Inflammatory Effects of Aprepitant In HIV-Infected Subjects

Phase 1

Completed

Conditions: HIV Infection

Interventions: Drug: Aprepitant

First Posted Date: 2014-06-03

Last Posted Date: 2017-08-17

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 12

Registration Number: NCT02154360

Locations: 🇺🇸
Hospital of the University of Pennsylvania Clinical Research Site, Philadelphia, Pennsylvania, United States

Social Forces to Improve Statin Adherence (Study B)

Not Applicable

Completed

Conditions: Diabetes
High Blood Pressure
Medication Adherence

Interventions: Behavioral: Adherence feedback
Behavioral: Comparison to peers
Device: Electronic pill bottle

First Posted Date: 2014-05-28

Last Posted Date: 2017-07-13

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 201

Registration Number: NCT02148523

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Comparing Behavioral Therapies for Treating Adolescents With Post-Traumatic Stress Disorder Related to Sexual Abuse

Phase 2

Completed

Conditions: PTSD

Interventions: Behavioral: Prolonged Exposure for Adolescents
Behavioral: Client Centered Therapy

First Posted Date: 2014-05-28

Last Posted Date: 2016-08-19

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 90

Registration Number: NCT02148484

Pilot Study of Clinician-supported Patient Self-management of Hospital Insulin Therapy

Not Applicable

Withdrawn

Conditions: Diabetes Mellitus

Interventions: Drug: glargine and aspart

First Posted Date: 2014-05-22

Last Posted Date: 2015-03-17

Lead Sponsor: University of Pennsylvania

Registration Number: NCT02144441

Locations: 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

Contraceptive Hormones and Women With Cystic Fibrosis

Phase 1

Terminated

Conditions: Cystic Fibrosis Exacerbations While on and Off Hormonal Contraception

Interventions: Other: Non-hormonal period
Drug: Ortho-cyclen, Ethinyl estradiol/norgestimate, 0.035 mg/0.250 mg

First Posted Date: 2014-05-21

Last Posted Date: 2016-01-08

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 5

Registration Number: NCT02144246

Locations: 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

The Impact of Contraception on Postpartum Weight Loss

Not Applicable

Completed

Conditions: Weight

Interventions: Drug: DMPA immediately postpartum
Drug: Implanon immediately postpartum

First Posted Date: 2014-05-21

Last Posted Date: 2017-02-17

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 100

Registration Number: NCT02144259

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Heartstrong Pilot Program

Not Applicable

Completed

Conditions: Acute Myocardial Infarction

Interventions: Behavioral: Social Influence
Behavioral: Electronic Pill Bottles
Behavioral: Financial Incentives

First Posted Date: 2014-05-15

Last Posted Date: 2017-05-03

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 17

Registration Number: NCT02139202

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Sustained Aeration of Infant Lungs Trial

Not Applicable

Completed

Conditions: Preterm Birth
Extreme Prematurity

Interventions: Procedure: Standard of Care
Procedure: Sustained Inflation

First Posted Date: 2014-05-15

Last Posted Date: 2023-04-06

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 460

Registration Number: NCT02139800

Locations: 🇺🇸
Sharp Mary Birch Hospital for Women & Newborns, San Diego, California, United States
🇸🇬
KK Women's and Children's Hospital, Singapore, Singapore
🇺🇸
Women & Infants Hospital of Rhode Island, Providence, Rhode Island, United States

and more 18 locations

CART-19 for Multiple Myeloma

Phase 1

Completed

Conditions: Multiple Myeloma

Interventions: Biological: CART-19 T cells

First Posted Date: 2014-05-12

Last Posted Date: 2023-06-22

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 13

Registration Number: NCT02135406

Locations: 🇺🇸
Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

Phenotypic and Genotypic Markers of Performance Vulnerability to Sleep Loss

Not Applicable

Completed

Conditions: Total Sleep Deprivation Then Sleep Restriction
Sleep Restriction Then Total Sleep Deprivation

Interventions: Behavioral: Sleep

First Posted Date: 2014-05-05

Last Posted Date: 2015-12-02

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 170

Registration Number: NCT02130791

Locations: 🇺🇸
Unit for Experimental Psychiatry, Sleep and Chronobiology Laboratory, Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy